Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study

被引:7
|
作者
Yang, Xiaoqin [1 ]
Yoo, Hyun Kyoo [2 ]
Amin, Suvina [3 ]
Cheng, Wendy Y. [4 ]
Sundaresan, Sanjana [4 ]
Zhang, Lujia [4 ]
Duh, Mei S. [4 ]
机构
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] AstraZeneca Rare Dis, Alex, Cambridge, England
[3] AstraZeneca, Gaithersburg, MD USA
[4] Anal Grp Inc, Boston, MA USA
关键词
Neurofibromatosis type 1; Plexiform neurofibromas; Caregiver burden; Work productivity loss; Activity impairment; Cross-sectional study; Zarit Burden Interview; WPAI; Quality of life; CHILDREN; DISEASE; ADOLESCENTS; MORBIDITY; DISTRESS; FAMILIES; PARENTS; YOUTH;
D O I
10.1007/s40120-022-00365-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction Patients with neurofibromatosis type 1 (NF1) may develop plexiform neurofibromas (PNs) that can cause disfigurement, pain, and dysfunction, and may even be life-threatening. Studies have indicated NF1-PN can substantially impact the quality of life (QoL) of pediatric patients. However, research on caregiver burden is scarce. Methods Caregivers of pediatric patients ages 2-18 years with NF1-PN in the USA were recruited through the Children's Tumor Foundation to participate in an online cross-sectional survey (December 2020-January 2021). Caregiver burden was measured using the Zarit Burden Interview (ZBI), and productivity loss from patientcare was measured using the Work Productivity and Activity Impairment questionnaire, adapted for caregiving (WPAI:CG). Results Ninety-five caregivers were recruited with a median age of 44.0 years. Most were female (88.4%), white/Caucasian (85.3%), and did not have NF1 or PN (86.3% and 89.5%, respectively). Commonly reported health conditions among caregivers include anxiety (48.4%) and depression (34.7%). On the ZBI (range 0-88; higher = greater burden), mean (SD) scores were 23.0 (13.8) and 12.7% of caregivers reported moderate-severe (scores 41-60) or severe burden (scores 61-88). Fifty-six caregivers were employed and working in the 7 days prior to completing the WPAI:CG. They reported missing an average of 6.9% of their working hours and an average reduction of 17.3% of on-the-job effectiveness, contributing to 22.3% loss in work productivity. Among all 95 caregivers, an average of 17.2% of regular daily activities were impaired. Conclusions The burden among caregivers of pediatric patients with NF1-PN is considerable and underscores an unmet need for better disease management.
引用
收藏
页码:1221 / 1233
页数:13
相关论文
共 50 条
  • [31] OBSERVATIONAL REGISTRY STUDY OF TREATMENT PRACTICES AND LONG-TERM OUTCOMES OF CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMAS (PN) INITIATING SELUMETINIB IN REALWORLD PRACTICE IN THE UNITED STATES (US): STUDY DESIGN AND METHODOLOGY
    Waanders, Angela
    Yohay, Kaleb
    Fang, Shona
    Wahlstrom, Svea
    Bornhorst, Miriam
    Meade, Julia
    Vallance, Kelly
    Rodriguez, Randolph de la Rosa
    NEURO-ONCOLOGY, 2023, 25
  • [32] Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial
    Shih, Chie-Schin
    Blakeley, Jaishri
    Clapp, D. Wade
    Armstrong, Amy E.
    Wolters, Pam
    Dombi, Eva
    Cutter, Gary
    Ullrich, Nicole J.
    Allen, Jeffrey
    Packer, Roger
    Goldman, Stewart
    Gutmann, David H.
    Plotkin, Scott
    Rosser, Tena
    Robertson, Kent
    Widemann, Brigitte
    Rhodes, Steven
    Angus, Steven
    Johnson, Gary
    Korf, Bruce
    Fisher, Michael J.
    CANCER RESEARCH, 2019, 79 (13)
  • [33] A PHASE-II RANDOMIZED TRIAL OF 13-CIS RETINOIC ACID (CRA) AND INTERFERON ALFA-2A (IFN) IN THE TREATMENT OF PLEXIFORM NEUROFIBROMA (PN) IN PATIENTS WITH NEUROFIBROMATOSIS TYPE-1 (NF1)
    NEEDLE, MN
    MOLLOY, PT
    PACKER, R
    FRIEDMAN, HS
    COHEN, BH
    JAKACKI, R
    KORF, B
    VAUGHAN, SN
    PHILLIPS, PC
    PEDIATRIC RESEARCH, 1995, 37 (04) : A151 - A151
  • [34] Treatment With Selumetinib for Cafe-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1
    Guo, Ya-Xin
    Wang, He-Xiao
    Wang, Shan-Shan
    Croitoru, David
    Piguet, Vincent
    Gao, Xing-Hua
    Xu, Xue-Gang
    JAMA DERMATOLOGY, 2024, 160 (03) : 366 - 368
  • [35] Nutrient intake in neurofibromatosis type 1: A cross-sectional study
    Ribeiro de Souza, Marcio Leandro
    Jansen, Ann Kristine
    Martins, Aline Stangherlin
    Carneiro Rodrigues, Luiz Oswaldo
    de Rezende, Nilton Alves
    NUTRITION, 2015, 31 (06) : 858 - 862
  • [36] Phase II pilot study of imatinib mesylate in neurofibromatosis (NF1) patients with plexiform neurofibromas.
    Robertson, K. A.
    Bowers, D. C.
    Yang, F.
    Vik, T.
    Ho, C.
    Croop, J.
    Walsh, L. E.
    Hingtgen, C.
    Pradhan, K. R.
    Hutchins, G.
    Fletcher, J. W.
    Cohen, M.
    Edwards-Brown, M.
    Travers, J. B.
    Yu, M.
    Nalepa, G.
    Denne, S.
    Ingram, D.
    Clapp, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Disease burden among patients with Arginase 1 deficiency and their caregivers: A multinational, cross-sectional survey
    Olofsson, Sara
    Lofvendahl, Sofia
    Widen, Julia
    Jacobson, Lena
    Lindgren, Peter
    Stepien, Karolina M.
    Arnoux, Jean-Baptiste
    Pico, Maria Luz Couce
    Teles, Elisa Leao
    Rudebeck, Mattias
    JIMD REPORTS, 2024, 65 (06): : 450 - 460
  • [38] Burden of care among caregivers of patients with Parkinson disease: A cross-sectional study
    Razali, Rosdinom
    Ahmad, Fazli
    Abd Rahman, Fairuz Nazri
    Midin, Marhani
    Sidi, Hatta
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2011, 113 (08) : 639 - 643
  • [39] Phase 1 trial of trametinib alone and in combination with dabrafenib in children and adolescents with relapsed solid tumors or neurofibromatosis type 1 (NF1) progressive plexiform neurofibromas (PN).
    Geoerger, Birgit
    Moertel, Christopher L.
    Whitlock, James
    McCowage, Geoffrey Brian
    Kieran, Mark W.
    Broniscer, Alberto
    Hargrave, Darren R.
    Hingorani, Pooja
    Kilburn, Lindsay Baker
    Mueller, Sabine
    Tseng, Lillian
    Nebot, Noelia
    Dasgupta, Kohinoor
    Russo, Mark W.
    Fox, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] The factors associated with the caregiving burden among family caregivers of pediatric patients with fractures: A descriptive cross-sectional study
    Dai, Qiaoyan
    Peng, Mingxia
    Li, Chunyan
    Deng, Sijia
    Huang, Peiyan
    Guo, Xuemei
    Yang, Yi
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 79 : 126 - 132